Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

33
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
33
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

509
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
509
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

28
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

41
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
41

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-urgency heart transplantation and outcome trade-offs: early post-transplant infection and mortality.

ESC heart failure·2026
Same author

Efficacy and safety of extravascular renal denervation in patients with resistant hypertension: a study protocol for a pilot, single-arm, multi-center, first-in-human study.

Clinical hypertension·2026
Same author

Effectiveness of an Intervention to Improve Guideline-Directed Medications for Patients With Acute Heart Failure: A Randomized Clinical Trial.

Journal of the American Heart Association·2026
Same author

Functional Nanovesicle-Embedded Hydrogel Biosensors for the Real-Time Monitoring of Queen Mandibular Pheromone in Both Aqueous and Gaseous Environments.

ACS applied materials & interfaces·2026
Same author

Epidemiologic and economic impact of introducing a National Immunization Program for herpes zoster vaccination on the prevention of herpes zoster and postherpetic neuralgia in South Korea, an ageing society.

Epidemiology and infection·2026
Same author

Sex- and phenotype-specific prognostic implications of body mass index in acute heart failure.

ESC heart failure·2026

Related Experiment Video

Updated: Sep 12, 2025

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.2K

Novel Approach to Acute Heart Failure Risk Stratification Using AI-Derived Congestion Index from Chest Radiographs

Ki-Hyun Jeon1, Taeho Hur1, Minjae Yoon1

  • 1Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Studies in Health Technology and Informatics
|August 8, 2025
PubMed
Summary
This summary is machine-generated.

This study created a machine learning Clinical Decision Support System (CDSS) for acute decompensated heart failure (ADHF). Integrating AI-derived chest X-ray data improved prediction accuracy, aiding patient risk stratification.

Keywords:
artificial intelligenceheart failure

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

214
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

876

Related Experiment Videos

Last Updated: Sep 12, 2025

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.2K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

214
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

876

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Acute decompensated heart failure (ADHF) poses significant clinical challenges.
  • Accurate risk stratification is crucial for managing ADHF patients.
  • Current methods may benefit from novel data integration.

Purpose of the Study:

  • To develop and validate a machine learning-based Clinical Decision Support System (CDSS) for ADHF.
  • To integrate an AI-derived Congestion Index (CIx) from chest X-rays with clinical and laboratory data.
  • To evaluate the predictive performance of the CDSS for patient outcomes.

Main Methods:

  • Development of a CDSS incorporating an AI-derived Congestion Index (CIx) from chest X-rays.
  • Integration of CIx with traditional clinical and laboratory data.
  • Retrospective analysis of 9,286 patients with ADHF.

Main Results:

  • The model incorporating imaging data achieved the highest predictive accuracy (AUROC 0.750).
  • The AI-derived Congestion Index (CIx) showed prognostic performance comparable to NT-proBNP.
  • Higher CIx quartiles were significantly associated with increased adverse event rates.

Conclusions:

  • AI-based imaging biomarkers, like CIx, enhance risk stratification in ADHF.
  • The developed CDSS shows promise for improving clinical decision-making in ADHF.
  • Integrating imaging data into decision support systems offers a valuable advancement in cardiology.